Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 3OKE | 3OKE | Crystal structure of S25-39 in complex with Ko | S25-39 Fab (IgG1k) light chain, S25-39 Fab (IgG1k) heavy chain |
| 3OKK | 3OKK | Crystal structure of S25-39 in complex with Kdo(2.4)Kdo | S25-39 Fab (IgG1k) light chain, S25-39 Fab (IgG1k) heavy chain |
| 3OKL | 3OKL | Crystal structure of S25-39 in complex with Kdo(2.8)Kdo | S25-39 Fab (IgG1k) light chain, S25-39 Fab (IgG1k) heavy chain |
| 3OKN | 3OKN | Crystal structure of S25-39 in complex with Kdo(2.4)Kdo(2.4)Kdo | S25-39 Fab (IgG1k) light chain, S25-39 Fab (IgG1k) heavy chain |
| 3OKO | 3OKO | Crystal structure of S25-39 in complex with Kdo(2.8)Kdo(2.4)Kdo | S25-39 Fab (IgG1k) light chain, S25-39 Fab (IgG1k) heavy chain |
| 7JVA | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | S2A4 Fab heavy chain, S2A4 Fab light chain, SARS-CoV-2 spike glycoprotein |
| 7JVA | 7JVA | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | S2A4 Fab heavy chain, S2A4 Fab light chain, SARS-CoV-2 spike glycoprotein |
| 7LXX | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
| 7LXX | 7LXX | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
| 7LXW | P0DTC2 | SARS-CoV-2 S/S2M11/S2X333 Local Refinement | S2X333 Fab Light Chain variable region, S2X333 Fab Heavy Chain variable region, Spike glycoprotein |
| 7LXW | 7LXW | SARS-CoV-2 S/S2M11/S2X333 Local Refinement | S2X333 Fab Light Chain variable region, S2X333 Fab Heavy Chain variable region, Spike glycoprotein |
| 3PHO | 3PHO | Crystal structure of S64-4 in complex with PSBP | S64-4 Fab (IgG1) light chain, S64-4 Fab (IgG1) heavy chain |
| 3PHQ | 3PHQ | Crystal structure of S64-4 in complex with KDO | S64-4 Fab (IgG1) light chain, S64-4 Fab (IgG1) heavy chain |
| 1FMU | P07267 | STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP. | SACCHAROPEPSIN (E.C. 3.4.23.25) |
| 1FMX | P07267 | STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21 | SACCHAROPEPSIN (E.C. 3.4.23.25) |
| 1FQ4 | P07267 | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 1FQ5 | P07267 | X-ray structure of a cyclic statine inhibitor PD-129,541 bound to yeast proteinase A | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 1FQ6 | P07267 | X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 1FQ7 | P07267 | X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 1FQ8 | P07267 | X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN | SACCHAROPEPSIN (E.C.3.4.23.25) |
| 6Z97 | P10104 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 RBD, Heavy Chain, Light chain |
| 6Z97 | P0DTC2 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 RBD, Heavy Chain, Light chain |
| 7CAB | P0DTC2 | Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody | SARS-CoV-2 Spike glycoprotein |
| 6X6P | P0DTC2 | Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis | SARS-CoV-2 spike glycoprotein |
| 6X79 | P0DTC2 | Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation | SARS-CoV-2 spike glycoprotein |
| 7L2D | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
| 7L2D | 7L2D | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
| 6XEY | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | 6XEY | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | A0A5C2GJG2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 7KSG | P0DTC2 | SARS-CoV-2 spike in complex with nanobodies E | SARS-CoV-2 spike glycoprotein, Nanobody against SARS-CoV-2 glycoprotein |
| 7KSG | 7KSG | SARS-CoV-2 spike in complex with nanobodies E | SARS-CoV-2 spike glycoprotein, Nanobody against SARS-CoV-2 glycoprotein |
| 7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain |
| 7JVC | 7JVC | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain |
| 7JV6 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain |
| 7JV6 | 7JV6 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain |
| 7K43 | P0DTC2 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain) |
| 7K43 | 7K43 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain) |
| 7JW0 | P0DTC2 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain |
| 7JW0 | 7JW0 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 7KKK | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 7KKK | 7KKK | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
